{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:42:31Z","timestamp":1781926951525,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,9]]},"DOI":"10.7759\/cureus.17842","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T11:08:46Z","timestamp":1631185726000},"source":"Crossref","is-referenced-by-count":4,"title":["Crimean-Congo Hemorrhagic Fever Beyond Ribavirin"],"prefix":"10.7759","author":[{"given":"Stephanie P","family":"Fabara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Fernando","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick Wayne","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashank","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashwath","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prarthana","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Tirupathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Crimean-Congo Hemorrhagic Fever (CCHF). (2019). Accessed. May 11, 2021: https:\/\/www.cdc.gov\/vhf\/crimean-congo\/index.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2019.09.005","article-title":"Crimean-Congo hemorrhagic fever: an update","volume":"49","author":"Fill\u00e2tre P","year":"2019","unstructured":"Fill\u00e2tre P, Revest M, Tattevin P. Crimean-Congo hemorrhagic fever: an update. Med Mal Infect. 2019, 49:574-85. 10.1016\/j.medmal.2019.09.005","journal-title":"Med Mal Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1309\/LMN1P2FRZ7BKZSCO","article-title":"Crimean-Congo hemorrhagic fever","volume":"46","author":"Shayan S","year":"2015","unstructured":"Shayan S, Bokaean M, Shahrivar MR, Chinikar S. Crimean-Congo hemorrhagic fever. Lab Med. 2015, 46:180-9. 10.1309\/LMN1P2FRZ7BKZSCO","journal-title":"Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jmedent\/15.4.307","article-title":"The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa","volume":"15","author":"Hoogstraal H","year":"1979","unstructured":"Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979, 15:307-417. 10.1093\/jmedent\/15.4.307","journal-title":"J Med Entomol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.06.011","article-title":"Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever","volume":"132","author":"Akinci E","year":"2016","unstructured":"Akinci E, Bodur H, Sunbul M, Leblebicioglu H. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever. Antiviral Res. 2016, 132:233-43. 10.1016\/j.antiviral.2016.06.011","journal-title":"Antiviral Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2012.1061","article-title":"Pathogenesis of Crimean-Congo hemorrhagic fever","volume":"13","author":"Ak\u0131nc\u0131 E","year":"2013","unstructured":"Ak\u0131nc\u0131 E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013, 13:429-37. 10.1089\/vbz.2012.1061","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3201\/eid2409.171709","article-title":"Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among Healthcare workers","volume":"24","author":"Erg\u00f6n\u00fcl \u00d6","year":"2018","unstructured":"Erg\u00f6n\u00fcl \u00d6, Keske \u015e, \u00c7eldir MG, et al.. Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among Healthcare workers. Emerg Infect Dis. 2018, 24:1642-8. 10.3201\/eid2409.171709","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.047589-0","article-title":"The importance of myeloperoxidase enzyme activity in the pathogenesis of Crimean-Congo haemorrhagic fever","volume":"62","author":"Guven FM","year":"2013","unstructured":"Guven FM, Aydin H, Yildiz G, Engin A, Celik VK, Bakir D, Deveci K. The importance of myeloperoxidase enzyme activity in the pathogenesis of Crimean-Congo haemorrhagic fever. J Med Microbiol. 2013, 62:441-5. 10.1099\/jmm.0.047589-0","journal-title":"J Med Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"10","author":"Soares-Weiser K","year":"2010","unstructured":"Soares-Weiser K, Thomas S, Thomson G, Garner P. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect Dis. 2010, 10:207. 10.1186\/1471-2334-10-207","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad MH","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018, 23:60-3. 10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid Based Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21875","article-title":"Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever","volume":"36","author":"Be\u015ftepe Dursun Z","year":"2021","unstructured":"Be\u015ftepe Dursun Z, Korkmaz S, T\u00fcre Z, Kaynar L, Dursun A, \u00c7elik \u0130. Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever. J Clin Apher. 2021, 36:390-7. 10.1002\/jca.21875","journal-title":"J Clin Apher"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26358","article-title":"A case of Crimean Congo hemorrhagic fever complicated with acute pulmonary embolism","volume":"93","author":"Ture Z","year":"2021","unstructured":"Ture Z, Kalin-Unuvar G. A case of Crimean Congo hemorrhagic fever complicated with acute pulmonary embolism. J Med Virol. 2021, 93:3925-8. 10.1002\/jmv.26358","journal-title":"J Med Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.04.011","article-title":"Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever","volume":"48","author":"Me\u00e7o BC","year":"2013","unstructured":"Me\u00e7o BC, Memiko\u011flu O, Ilhan O, et al.. Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever. Transfus Apher Sci. 2013, 48:331-4. 10.1016\/j.transci.2013.04.011","journal-title":"Transfus Apher Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1258\/td.2011.100470","article-title":"A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin","volume":"41","author":"Kurnaz F","year":"2011","unstructured":"Kurnaz F, Metan G, Coskun R, Kaynar L, Eser B, Doganay M. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin. Trop Doct. 2011, 41:181-2. 10.1258\/td.2011.100470","journal-title":"Trop Doct"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz B","year":"2013","unstructured":"Dokuzoguz B, Celikbas AK, G\u00f6k \u015eE, Baykam N, Eroglu MN, Erg\u00f6n\u00fcl \u00d6. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013, 57:1270-4. 10.1093\/cid\/cit527","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5359.26609","article-title":"Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004)","volume":"60","author":"Jabbari A","year":"2006","unstructured":"Jabbari A, Besharat S, Abbasi A, Moradi A, Kalavi K. Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004). Indian J Med Sci. 2006, 60:327-9. 10.4103\/0019-5359.26609","journal-title":"Indian J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3182706444","article-title":"The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma","volume":"35","author":"Erduran E","year":"2013","unstructured":"Erduran E, Bahadir A, Palanci N, Gedik Y. The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma. J Pediatr Hematol Oncol. 2013, 35:e19-24. 10.1097\/MPH.0b013e3182706444","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref20","article-title":"Comparative study between ribavirin and ribavirin plus intravenous immunoglobulin against Crimean Congo hemorrhagic fever","volume":"18","author":"Salehi H","year":"2013","unstructured":"Salehi H, Salehi M, Adibi N, Salehi M. Comparative study between ribavirin and ribavirin plus intravenous immunoglobulin against Crimean Congo hemorrhagic fever. J Res Med Sci. 2013, 18:497-500.","journal-title":"J Res Med Sci"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.7883\/yoken.64.439","article-title":"Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR","volume":"64","author":"Kubar A","year":"2011","unstructured":"Kubar A, Haciomeroglu M, Ozkul A, Bagriacik U, Akinci E, Sener K, Bodur H. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis. 2011, 64:439-43.","journal-title":"Jpn J Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.11.002","article-title":"Treatment of Crimean-Congo hemorrhagic fever","volume":"78","author":"Ergonul O","year":"2008","unstructured":"Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 2008, 78:125-31. 10.1016\/j.antiviral.2007.11.002","journal-title":"Antiviral Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66897-crimean-congo-hemorrhagic-fever-beyond-ribavirin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:43Z","timestamp":1707507223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66897-crimean-congo-hemorrhagic-fever-beyond-ribavirin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.17842","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}